Boerhaavia diffusa Linn. has been shown to exhibit a wide range of medicinal properties for the treatment of diabetes, inflammation, stress, hepatotoxicity, jaundice and heart failure. The extraordinary antioxidant, hepatoprotective, antibiotic, antidiabetic and anticarcinogenic properties of B. diffusa have attracted pioneers in the field of science and medicine. Moreover, the therapeutic importance of this plant, which is due to presence of polyphenols and flavanoids, makes this plant medically more important to be exploited by clinicians and scientists to gain more insight into its biological and medicinal properties. The present review on B. diffusa focuses over the chemical compositions and its ethno-medicinal uses, linked from ancient times to the present with a scope of development in future. Furthermore, a recent update on mechanistic approaches of B. diffusa has also been discussed, which could be helpful for the researchers working in this field. Eventually, based on its antioxidant and antidiabetic characteristics, it is hypothesized that B. diffusa might exhibit antiglycating properties as well.
INTRODUCTION
Boerhaavia diffusa Linn., a herbaceous member of family Nyctaginaceae, is also known as Punarnava, Raktapunarnava, Shothaghni, Kathillaka, Kshudra, Varshabhu, Raktapushpa, Varshaketu amd Shilatika in India (Yelne et al., 2000) . There are several species of genus Boerhaavia which are distributed in the tropical, subtropical and temperate regions throughout the world like Australia, Asia, U.S.A., and Africa. B. diffusa is indigenous to India and found throughout the warmer parts of the country up to an altitude of 2000 m in the Himalayan region (Dhar et al., 2011) . Out of the 40 species of this genus, six are found in India e.g. B. diffusa, B. chinensis, B. erecta, B. repens, B. rependa, and B. rubicunda. The preliminary screening of the B. diffusa plant revealed the presence of sugars, sterols (Singh and Udupa, 1972) , β-sitosterol (Srivastava et al., 1972) and alkaloids (Garg et al., 1980; Shukla, 1982) . Surange and Pendse (1972) also reported the presence of alkaloids (0.04%) known as punarnavine and punarnavoside. Misra and Tiwari (1971) isolated hentriacontane, β-sitosterol and ursolic acid along with glucose, fructose and sucrose from the roots of B. diffusa. Ahmed and Yu (1992) isolated a new dihydroisofuranoxanthone from the benzene extract of the roots of B. diffusa and its structure was elucidated as methyl 3,10-dihydro-11-hydroxy-1-methoxy-4,6-dimethyl-10-oxo-1H-furo [3,4-b] xanthene-3-carboxylate and designated as borhavine (Ahmed and Yu, 1992) . A C-methyl flavone characterized as 5,7-dihydroxy-6-8-dimethoxy flavones was also reported from root (Gupta and Ahmad, 1984) .
The most interesting metabolites from the therapeutic point of view are the rotenoids which are known as boeravinones (boeravinone A-F) and have been isolated from the roots of B. diffusa plant (Misra and Tewari, 1971; Jain and Khanna, 1989; Kadota et al., 1989; Lami et al., 1992) (Figure 1 ). Two lignans, liriodendrin and syringaresinol mono-beta-D-glucoside, have been isolated from the methanol extract of the roots of B. diffusa and the former compound was found to exhibit a significant calcium (Ca2 + ) channel antagonistic effect in frog heart single cells (Lami et al., 1991) . Gupta and Ali (1998) isolated four new compounds from the root namely boerhavisterol, boerhadiffusene, diffusarotenoid, boerhavilanastenyl benzoate and a rotenoid, boerhavinone A and their structures were elucidated as 9,10-seco-stigmast-5,8 (9)-dien-3β-ol; 1-(2',6',6'-trimethylcyclohex-1 ' -enyl) -11-(3"-3"-dimethyl cyclohexyl) -4,8-dimethy l-undiec-1-ene; 4,9-dihydroxy-10-methyl-6a-dehydrorotenoid-6-pentanoate; 27-O-(4'-benzoyl-β-Dglucopyranosyl) 9β-lanost-5-en-3-one and 6-methoxy-9,11-dihydroxy-10-methyl-6-a, 12a-dihydrorotenoid, respectively .
. (Gupta and Ali, 1998) . Punarnavoside, a phenolic glycoside is reportedly present in roots (Seth et al., 1986) . Punarnavoside was later characterized as 2-glucopyrano-4-hydroxy-5-(p-hydroxy phenyl) propionyldiphenylmethane (Jain and Khanna, 1989) . Maurya et al. (2007) isolated four new compounds from B. diffusa (Maurya et al., 2007) .
Pharmacological and Clinical properties of B. diffusa
Various parts of B. diffusa are used for the treatment of numerous disorders in different parts of India. The root, leaves, aerial parts or the whole plant of B. diffusa have been employed for the treatment of various disorders in the Ayurvedic herbal medicine. The pharmacological studies have demonstrated that the roots of B. diffusa exhibit a wide range of properties such as anti-inflammatory (Bhalla et al., 1971) , diuretic (Gaitonde et al., 1974) , laxative (Chopra et al., 1956) , antiurethritis (Nadkarni, 1976) , anticonvulsant (Adesina, 1979) , antinematodal (Vijayalakshmi et al., 1979) , antifibrinolytic Khanna, 1989), antibacterial (Olukoya et al., 1993) , antihepatotoxic (Mishra, 1980; Chandan et al., 1991; Rawat et al., 1997) , anthelmintic, antileprotic, antiasthmatic, antiscabby and antistress activities (Figure 2 ). The flowers and seeds are used as a contraceptive (Chopra et al., 1956) .
The leaf extracts from B. diffusa has been shown to have hepatoprotective, antioxidant, antinociceptive, antibacterial and antidiabetic properties (Dhar et al., 2011) . Toxicological studies conducted on B. diffusa demonstrated the absence of teratogenic and mutagenic effects (Singh et al., 1991) . Some of the therapeutically important properties of B. diffusa are described below: 
Antioxidant and Genoprotective properties
Excessive generation of free radicals, known as oxidative stress, is one of the major causes of various diseases like diabetes, cancer, cardiovascular diseases etc. There are several antioxidants or plant phytochemicals which are known to ameliorate the various damages caused by oxidative stress (Khan et al., 2011a; Khan et al., 2011b) . B. diffusa possess a rotenoid named boeravinone G, which has been shown to be a very powerful antioxidant and genoprotective agent (Yelne et al., 2000; Aviello et al., 2011) . These effects of rotenoids help in the prevention against the diseases caused by free radicals, cancer and aging which cause damages to DNA macromolecules. The extraordinary antioxidant property of boeravinone G could possibly be used in the near future in order to develop drugs against different pathological conditions and those related to reactive oxygen species (ROS)-mediated injuries.
Antiproliferative and Anticarcinogenic properties
There are only few reports which have strongly shown the antiproliferative and anticarcinogenic potential of B. diffusa (Mehrotra et al., 2002; Srivastava et al., 2009) . Mehrotra et al. (2002) (Mehrotra et al., 2002) .
A previous study has established that a methanol: chloroform fraction of B. diffusa (BDF 5) could inhibit the proliferation of human cervical cancer HeLa cell line (Srivastava et al., 2009) . The S-phase inhibition of the cell cycle and apoptosis played important roles in B. diffusa-induced antiproliferative activity against HeLa cells. Moreover, the alcoholic and water extracts of B. diffusa is known to contain several bioactive molecules such as reducing sugars, starch and lignans, liriodendrin, syrigaresinol and several boeravinones (boeravinone A-J.) The activity shown by the BDF 5 has been attributed to these diverse compounds. In another study, two rotenoids isolated from B. diffusa, boeravinones G and H, have been found to potently inhibit the drug efflux activity of breast cancer resistance protein (BCRP/ABCG2), a multidrug transporter responsible for cancer cell resistance to chemotherapy (Ahmed-Belkacem et al., 2007) . Thus, these studies provided enough evidences to further explore the potential of this plant in the chemoprevention and management of cancer.
Immunomodulatory properties
Immunoregulation is a complex balance between regulatory and effector cells and any imbalance in the immunological mechanism may lead to pathogenesis of several diseases. Modulation of the immune system is an emerging trend in chemotherapeutic research. Immunomodulators are materials which can modify the body's defense mechanism either by There are many reports which have demonstrated the immunomodulatory properties of B. diffusa. Pandey et al. (2005) evaluated the effect of hexane, chloroform and ethanol extracts of B. diffusa and two pure compounds Bd-I (eupalitin-3-O-beta-Dgalactopyranoside) and Bd-II (eupalitin) on T cell mitogen (phytohemagglutinin; PHA) stimulated proliferation of human peripheral blood mononuclear cell (PBMC), mixed lymphocyte culture, lipopolysaccharide (LPS) stimulated nitric oxide production by RAW 264.7, PHA and LPS induced IL-2 and TNF-α production, in human PBMCs, superoxide production in neutrophils, human natural killer (NK) cell cytotoxicity and nuclear translocation of nuclear factor-kappa B and AP-1 in PHA stimulated PBMCs. The results showed that chloroform and ethanol extracts inhibited PHA stimulated proliferation of peripheral blood mononuclear cells, NK cell cytotoxicity as well as LPS induced NO production by RAW 264.7; the hexane extract showed no activity. Bd-I inhibited PHA-stimulated proliferation of peripheral blood mononuclear cells, NK cell cytotoxicity as well as LPS induced NO production by RAW 264.7 equally or more effectively than the parent ethanolic extract. Bd-I inhibited production of PHA stimulated IL-2 at the protein and mRNA transcript levels and LPS stimulated TNF-α production in human PBMCs; it also blocked the activation of DNA binding of nuclear factor-kappa B and AP-1, two major transcription factors centrally involved in expression of the IL-2 and IL-2R gene, which are necessary for T cell activation and proliferation (Pandey et al., 2005) . Mehrotra et al. (2002) evaluated the immunomodulatory properties of this plant extract on various in vitro tests such as human natural killer (NK) cell cytotoxicity, production of nitric oxide (NO) in mouse macrophage cells, RAW 264.7, IL-2, tumor necrosis factor-α (TNF-α), intracytoplasmic interferon-γ (IFN-γ) and expression of various cell surface markers on human peripheral blood mononuclear cells (PBMCs). This study established that ethanolic extracts of B. diffusa roots inhibited human NK cell cytotoxicity in vitro, production of NO in mouse macrophage cells, IL-2 and TNF-α in human PBMCs. Intracytoplasmic IFN-γ and cell surface markers such as CD16, CD25, and HLA-DR did not get affected on treatment with B. diffusa extract (Mehrotra et al., 2002) . Manu and Kuttan (2008) studied the effect of B. diffusa extract on the cell mediated immune (CMI) response against metastatic progression of B16F-10 melanoma cells in C57BL/6 mice model and observed that administration of B. diffusa extract enhanced natural killer (NK) cell activity, antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent complement mediated cytotoxicity (ACC). Production of the cytokine IL-2 was significantly enhanced by the administration of B. diffusa compared to the untreated metastatic tumor bearing control. Levels of GM-CSF and pro-inflammatory cytokines such as IL-1β, IL-6 and TNF-α were significantly lowered by B. diffusa administration compared to metastatic control (Manu and Kuttan, 2008) . The gene expression level of IL-2, IL-1β, IL-6, TNF-α and GM-CSF in B16F-10 cells also correlated the above result. In another study, Manu and Kuttan (2009) studied the effect of punarnavine, an alkaloid from B. diffusa, on the immune system using Balb/c mice and observed that intraperitoneal administration of punarnavine enhanced the proliferation of splenocytes, thymocytes and bone marrow cells both in the presence and absence of specific mitogens in vitro and in vivo. More over administration of punarnavine significantly reduced the lipopolysaccharide (LPS) induced elevated levels of proinflammatory cytokines such as TNF-α, IL-1β, and IL-6 in mice (Manu and Kuttan, 2009 ).
Antiinflammatory properties
Ethanol extract of B. diffusa leaves exhibited antiinflammatory effect with carrageen, serotonin, histamine and dextran induced rat paw edema models, respectively (Bhalla et al., 1971) .
Hepatoprotective properties
The roots of B. diffusa are used by a large number of tribes in India for the treatment of various hepatic disorders and for internal inflammation Clinical data has reported effectiveness of B. diffusa in cases of oedema and ascites resulting from early cirrhosis of the liver and chronic peritonitis. An aqueous extract of thinner roots of B. diffusa exhibited the remarkable protection of various enzymes such as serum glutamic-oxaloacetic transaminase and glutamic-pyruvic transaminase against thioacetamide induced hepatic injury in rats (Rawat et al., 1997) . The aqueous root extract of B. diffusa also showed the hepatoprotective activity against the toxic effects generated by carbon tetrachloride in the liver (Chandan et al., 1991) . Surange and Pendse (1972) studied the effect of ethanol root extract of B. diffusa on country made liquor induced hepatotoxicity in albino rats and observed that B. diffusa extract protected the rats from hepatotoxic action of liquor by ameliorating the alanine aminotransferase (ALT), triglyceride, cholesterol and total lipid levels in both serum and tissues (Surange and Pendse, 1972) . Histopathological studies also showed marked reduction in fat deposits in animals receiving B. diffusa along with country made liquor. The aerial parts of B. diffusa have also been reported to exhibit the hepatoprotective activity (Chakraborti and Handa, 1989) . The hepatoprotective properties of B. diffusa have been attributed to ursolic acid. Olaleye et al. (2010) also evaluated the antioxidant and hepatoprotective properties of leaf extract of B. diffusa in the acetaminophen-induced liver damage model and found that pretreatment with aqueous and ethanolic extracts decreased the activities of alkaline phosphatase, lactate dehydrogenase, alanine aminotransferase, aspartate aminotransferase, and the level of bilirubin in the serum that were elevated by acetaminophen. The extracts also protected against acetaminophen induced lipid peroxidation (Olaleye et al., 2010) .
Antibacterial properties
The leaves of B. diffusa have been shown to exhibit potent antibacterial activity against various Gram-negative and Gram-positive bacteria which might be due to various phytochemicals present in the leaves (Olukoya et al., 1993; Awasthi and Verma, 2006) . The ethanol extract of the plant showed an inhibitory effect on Gram-positive bacteria like Staphylococcus aureus, Bacillus subtilis, Streptococcus faecalis, Micrococcus luteus and all Gram-negative bacteria. In addition, methanol extract demonstrated an inhibitory effect against all Gram-positive bacteria, however, Micrococcus luteus and Gramnegative bacteria like Klebsiella pneumoniae, Proteus vulgaris, Serratia marcescens and Shigella flexneri showed no inhibitory effect (Awasthi and Verma, 2006) .
Anticonvulsant properties
Kaur and Goel (2011) investigated the possible anticonvulsant properties of the methanol root extract of B. diffusa and its different fractions including a calcium channel antagonist, liriodendrin-rich fraction in pentylenetetrazol (PTZ)-induced seizures in mice and observed that the crude methanol extract of B. diffusa and only its liriodendrin-rich fraction showed a dosedependent protection against PTZ-induced convulsions. The liriodendrin-rich fraction also showed significant protection against seizures induced by BAY k-8644, a calcium channel agonist. These findings reiterated the anticonvulsant activity of methanol extract of B. diffusa roots (Kaur and Goel, 2011).
Hypolipidemic properties
High blood cholesterol results in atherosclerosis, which is characterized by presence of atheromas. There are several reports illustrating the role of natural products like vitamin E, in combating cardiovascular diseases (Khan et al., 2011c; Iqbal et al., 2012) . Recent investigations have revealed the efficacy of B. diffusa as an antioxidant and hypolipidemic agent by analyzing all the parameters in plasma lipoprotein lipids, total cholesterol (TC), triglyceride (TG), very low-density lipoprotein cholesterol (VLDL-C), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), malondialdehyde (MDA) and in-vitro oxidizability of LDL. In a recent study, all the plasma lipid parameters were found to be significantly increased in hyperlipidemic control rats and administration of B. diffusa extract significantly reduced the overall oxidative burden and effectively ameliorated the above altered parameters (Khan et al., 2011) .
Hypoglycemic properties
The methanol and ethanol extracts of B. diffusa exhibited significant anti-hyperglycemic activities in alloxan as well as in streptozotocin-induced hyperglycemic rats (Bhatia et al., 2011) . Both the extracts from B. diffusa have also been shown improve the condition of diabetes as indicated by parameters like body weight along with serum cholesterol and triglyceride levels. The extracts of B. diffusa showed significant increase in glucose tolerance, but methanol extract exhibited more activity (Bhatia et al., 2011) . In alloxan-induced diabetic rats, the maximum percentage reduction in blood glucose level was found in the rats treated with methanol extract of B. diffusa. Animals, which received streptozotocin (STZ), also showed a significant reduction in body weight, and increase in water and food intake as compared to vehicle control, which was significantly reversed by methanol extracts of B. diffusa after few weeks of treatment (Bhatia et al., 2011) . In another study, the chloroform extract of B. diffusa leaves produced dose-dependent reduction in blood glucose in STZinduced non insulin dependent diabetes mellitus (NIDDM) rats comparable to that of glibenclamide, an antidiabetic drug (Nalamolu et al., 2004) . Pari and Amarnath Satheesh (2004) investigated the effects of oral administration of aqueous solution of B. diffusa L. leaf extract on blood glucose concentration and hepatic enzymes in normal and alloxan-induced diabetic rats and observed a significant decrease in blood glucose and increase in plasma insulin levels in normal and diabetic rats. Treatment with B. diffusa L. leaf extract resulted in a significant reduction of glycosylated haemoglobin and an increase in total haemoglobin level. The activities of the hepatic enzymes such as hexokinase was significantly increased and glucose-6-phosphatase, fructose-1,6-bisphosphatase were significantly decreased by the administration of extract in normal and diabetic rats. A comparison was made between the action of leaf extract and glibenclamide and the effect of extract was found more prominent when compared to glibenclamide (Pari and Amarnath Satheesh, 2004) .
Antiglycating properties of B. diffusa: a future perspective B. diffusa has been traditionally used in treating different ailments due to its multiple pharmacological activities viz., immunomodulatory, antidiabetic, analgesic, hepatoprotective, antiviral and anti-fibrinolytic activity etc. The therapeutic importance of plants is mainly due to polyphenols and their antioxidant properties. As discussed earlier, B. diffusa ethanol extract (BDE) showed significant scavenging activity against hydroxyl and superoxide radical. It also significantly inhibited the lipid peroxidation in linoleic acid emulsion system. Antioxidant activity of BDE was also evident from its significant reducing power and ferrous ion chelating potency. Thus, the data obtained from in vitro models clearly established the antioxidant potency of BDE (Aftab et al., 1996) . Furthermore, our previous study has shown that DNA and proteins undergo glycation reaction in the hyperglycemic conditions and these reaction produces highly reactive free radical species i.e., hydroxyl radical and superoxide anions which cause damage to the DNA and protein macromolecule Mustafa et al., 2011; Ahmad et al., 2011) . Since, it is well established that BDE has potent scavengers of these free radicals; it may also protect biological macromolecules to get damaged further, which in turn reverses or stops the glycation reaction. In the light of the above explanation, we hypothesize that the ethanol extract of B. diffusa might be useful as antiglycating agent apart from antidiabetic and antioxidant properties.
CONCLUSION
In recent year major thrust by whole of the pharmaceutical industry is focused towards design and development of new innovative/indigenous plant based drugs through investigation of leads from traditional system of medicine. Ethno-botanical and traditional uses of natural compounds, especially of plant origin received much attention as they are well tested for their efficacy and generally believed to be safe for human use. Numerous investigations on B. diffusa have now established that it is an important medicinal plant having a plethora of chemical constituents effective against a large number of ailments. However, further extensive biochemical and molecular investigations are needed in order to identify the active components involved in various pharmacological activities. Furthermore, our novel hypothesis of antiglycating properties of the plant extract could help in better understanding and prevention of bio-macromolecule (DNA and protein) damage in hyperglycemic condition which in turn could help in prevention of onset of several diseases linked to the glycation reaction like, diabetes, arthritis and ageing.
